What You Should Know: – Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry’s most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures. – The company uses proprietary AI models trained on matched multi-omic samples and clinical outcomes to predict how specific patient populations wi...